Jacobs Levy Equity Management, Inc T2 Biosystems, Inc. Transaction History

Jacobs Levy Equity Management, Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 May 15, 2018	SELL	$4.21 - $7.0 $360,460 - $599,340	-85,620 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$3.73 - $4.6 $319,362 - $393,851	85,620	85,620 $353,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.